Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
The Global Dental Device Market to hit $12.7 Billion by 2020 Propelled by a Surge in Oral Diseases and Poor Oral Hygiene: ABMRG PR Newswire LONDON and NEW YORK, December 9, 2014 LONDON and NEW...
Linden Capital Partners Completes Acquisition of Young Innovations, Inc. /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; }...
Young Innovations Announces Shareholder Approval of Merger with Affiliates of Linden Capital Partners /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black;...
Young Innovations Announces Expiration of "Go-Shop" Period /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li...
Levi & Korsinsky is investigating the Board of Directors of Young Innovations, Inc. (“Young Innovations” or the “Company”) (NasdaqGS: YDNT) for possible breaches of fiduciary...
Young Innovations Announces Date of Special Meeting of Shareholders, Early Termination of Hart-Scott-Rodino Waiting Period and Preliminary Results of Go-Shop Process /* Style Definitions...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Young Innovations, Inc. (YDNT), Compuware Corp. (CPWR), Caribou Coffee Co. Inc. (CBOU) and Somaxon Pharmaceuticals...
Lifshitz Law Firm Announces Investigation of Caribou Coffee Company, Inc., Epoch Holding Corporation, Somaxon Pharmaceuticals, Inc. and Young Innovations, Inc. /* Style Definitions...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Intermec Inc. (IN), Somaxon Pharmaceuticals, Inc. (SOMX), Clearwire Corp. (CLWR) and Young Innovations, Inc. (YDNT) /...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
